JC
Jacob Chacko (PRESIDENT AND CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ORIC Pharmaceuticals, Inc. (ORIC). The largest single filing was $302K of ORIC (33,374 sh × $9.06, as filed), executed Dec 16 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$302K
shares × price, as filed
Last traded
Dec 16 2025
Filed Dec 17 2025
Median ADV $20.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ORICRecent filings
ORICSALE
ORIC Pharmaceuticals, Inc.
View filing →
$302K33,374 sh × $9.06
Exec Dec 16 2025
Filed Dec 17 2025 · 5:30 PM ET ORICSALE ORIC Pharmaceuticals, Inc. View filing → $462K
37,461 sh × $12.32
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET ORICSALE ORIC Pharmaceuticals, Inc. View filing → $1.1M
87,539 sh across 2 lots
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET ORICSALE ORIC Pharmaceuticals, Inc. View filing → $1.4M
125,000 sh × $10.80
Exec Sep 22 2025
Filed Sep 24 2025 · 5:30 PM ET ORICSALE ORIC Pharmaceuticals, Inc. View filing → $204K
24,660 sh × $8.28
Exec Dec 16 2024
Filed Dec 17 2024 · 5:30 PM ET